Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson’s Disease

Background: Subthalamic nucleus deep brain stimulation (STN-DBS) is well-known to reduce medication burden in advanced stage Parkinson’s disease (PD). Preliminary data from a prospective, single blind, controlled pilot trial demonstrated that early stage PD subjects treated with STN-DBS also require...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Parkinsons Dis
Autores principales: Hacker, Mallory L., Currie, Amanda D., Molinari, Anna L., Turchan, Maxim, Millan, Sarah M., Heusinkveld, Lauren E., Roach, Jonathon, Konrad, Peter E., Davis, Thomas L., Neimat, Joseph S., Phibbs, Fenna T., Hedera, Peter, Byrne, Daniel W., Charles, David
Formato: Artigo
Lenguaje:Inglês
Publicado: IOS Press 2016
Materias:
Research Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4927876/
https://ncbi.nlm.nih.gov/pubmed/26967937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-150712
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares